Neridronic acid
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
(6-Amino-1-hydroxyhexane-1,1-diyl)bis(phosphonic acid) | |
| Identifiers | |
| CAS Number |
79778-41-9 |
| ATC code | none |
| PubChem | CID 71237 |
| ChemSpider |
64372 |
| UNII |
8U27U3RIN4 |
| Chemical data | |
| Formula | C6H17NO7P2 |
| Molar mass | 277.14 g/mol |
| |
| |
| | |
Neridronic acid (INN; the anion is called neridronate) is a bisphosphonate. In Italy it is used to treat Osteogenesis imperfecta and Paget's disease of bone.[1]
A 2013 clinical trial suggests CRPS Type I (Complex regional pain syndrome) responds to treatment with intravenous neridronate.[2]
References
| ||||||||||||||
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
